Talisman

Phase 2 Study Evaluating Different Medications to See If They May Help with GPRC5D-related Oral Events

What's the purpose of the trial?

The purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste dysfunction (hypogeusia), during the study treatment phase, and to better characterize the signs or symptoms of talquetamab-related taste dysfunction.
Trial status

Accepting patients

Phase
Phase 2
Enrollment
210
Last Updated

Participating Centers

There are 8 centers participating in this trial. Enter a location below to find the closest center.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Talquetamab

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.